Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta
- PMID: 34069814
- PMCID: PMC8157281
- DOI: 10.3390/ijms22105290
Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta
Abstract
Osteogenesis imperfecta (OI) is a bone fragility disorder that is usually caused by mutations affecting collagen type I. We compared the calvaria bone tissue transcriptome of male 10-week-old heterozygous Jrt (Col1a1 mutation) and homozygous oim mice (Col1a2 mutation) to their respective littermate results. We found that Jrt and oim mice shared 185 differentially expressed genes (upregulated: 106 genes; downregulated: 79 genes). A total of seven genes were upregulated by a factor of two or more in both mouse models (Cyp2e1, Slc13a5, Cgref1, Smpd3, Ifitm5, Cthrc1 and Rerg). One gene (Gypa, coding for a blood group antigen) was downregulated by a factor of two or more in both OI mouse models. Overrepresentation analyses revealed that genes involved in 'ossification' were significantly overrepresented among upregulated genes in both Jrt and oim mice, whereas hematopoietic genes were downregulated. Several genes involved in Wnt signaling and transforming growth factor beta signaling were upregulated in oim mice, but less so in Jrt mice. Thus, this study identified a set of genes that are dysregulated across various OI mouse models and are likely to play an important role in the pathophysiology of this disorder.
Keywords: RNA sequencing; Wnt signaling; osteogenesis imperfecta; transforming growth factor beta.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript or in the decision to publish the results.
Figures





Similar articles
-
Muscle transcriptome in mouse models of osteogenesis imperfecta.Bone. 2021 Jul;148:115940. doi: 10.1016/j.bone.2021.115940. Epub 2021 Mar 31. Bone. 2021. PMID: 33812081
-
Pleiotropic effects of a recessive Col1a2 mutation occurring in a mouse model of severe osteogenesis imperfecta.PLoS One. 2025 Feb 5;20(2):e0309801. doi: 10.1371/journal.pone.0309801. eCollection 2025. PLoS One. 2025. PMID: 39908220 Free PMC article.
-
Cardiac health, type I collagen, and aging in the oim/oim mouse model of osteogenesis imperfecta and a cohort of adults with OI.Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H565-H580. doi: 10.1152/ajpheart.00535.2024. Epub 2025 Feb 4. Am J Physiol Heart Circ Physiol. 2025. PMID: 39902996 Free PMC article.
-
OIM and related animal models of osteogenesis imperfecta.Connect Tissue Res. 1995;31(4):265-8. doi: 10.3109/03008209509010820. Connect Tissue Res. 1995. PMID: 15612365 Review.
-
[Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].Clin Calcium. 2010 Aug;20(8):1190-5. Clin Calcium. 2010. PMID: 20675929 Review. Japanese.
Cited by
-
Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life.Int J Mol Sci. 2022 Dec 22;24(1):184. doi: 10.3390/ijms24010184. Int J Mol Sci. 2022. PMID: 36613624 Free PMC article. Review.
-
The Osteocyte Transcriptome: Discovering Messages Buried Within Bone.Curr Osteoporos Rep. 2021 Dec;19(6):604-615. doi: 10.1007/s11914-021-00708-5. Epub 2021 Nov 10. Curr Osteoporos Rep. 2021. PMID: 34757588 Free PMC article. Review.
-
Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta.Sci Rep. 2023 Mar 27;13(1):5010. doi: 10.1038/s41598-023-32221-3. Sci Rep. 2023. PMID: 36973504 Free PMC article.
-
Exploration of the skeletal phenotype of the Col1a1 +/Mov13 mouse model for haploinsufficient osteogenesis imperfecta type 1.Front Endocrinol (Lausanne). 2023 Mar 8;14:1145125. doi: 10.3389/fendo.2023.1145125. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36967771 Free PMC article.
-
Targeting Longevity Gene SLC13A5: A Novel Approach to Prevent Age-Related Bone Fragility and Osteoporosis.Metabolites. 2023 Dec 6;13(12):1186. doi: 10.3390/metabo13121186. Metabolites. 2023. PMID: 38132868 Free PMC article.
References
-
- Bardai G., Moffatt P., Glorieux F.H., Rauch F. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: Diagnostic yield and mutation spectrum. Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA. 2016;27:3607–3613. doi: 10.1007/s00198-016-3709-1. - DOI - PubMed
-
- Chipman S.D., Sweet H.O., McBride D.J., Davisson M.T., Marks S.C., Shuldiner A.R., Wenstrup R.J., Rowe D.W., Shapiro J.R. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA. 1993;90:1701–1705. doi: 10.1073/pnas.90.5.1701. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous